Related Experiment Videos
Ca2+ or Mg2+ nucleotide phosphohydrolases in myometrium: two ecto-enzymes
1Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905.
Biochimica Et Biophysica Acta
|November 18, 1991
Summary
Myometrial cells possess two distinct ecto-enzymes on their surface. These enzymes hydrolyze nucleotides and are unaffected by oxytocin, suggesting a role in regulating purinergic receptors.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Myometrial cells exhibit significant ecto-enzyme activity.
- This activity is associated with Ca2+ or Mg2+ nucleotide phosphohydrolase.
- The enzymes are located on the cell surface and in plasma membranes.
Purpose of the Study:
- To characterize the Ca2+ or Mg2+ nucleotide phosphohydrolase activity on myometrial cells.
- To differentiate between labile and stable components of this activity.
- To investigate the enzymes' response to oxytocin and potential roles.
Main Methods:
- Isolation of myometrial plasma membranes.
- Assay of nucleotide phosphohydrolase activity using various substrates and inhibitors.
- Determination of kinetic parameters (Km) and inhibition profiles.
- Testing the effect of oxytocin on enzyme activity.
Main Results:
- Two distinct ecto-enzymes were identified: a stable and a labile component.
- The stable enzyme accepts XTP/XDP, while the labile enzyme cleaves XTP only.
- Labile enzyme activity is sensitive to product inhibition by inorganic orthophosphate.
- Neither enzyme was inhibited by oxytocin up to 10 microM.
Conclusions:
- Myometrial cells possess at least two distinct ecto-enzymes with differing substrate specificities and sensitivities.
- Product inhibition significantly impacts the labile enzyme's activity.
- These ecto-enzymes are not directly regulated by oxytocin, unlike the Ca2+ pump.
- The labile enzyme may play a role in regulating purinergic receptors due to its activity and inhibition characteristics.